Vivos (RDGL) EBT Margin Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Vivos | - | - | -3,105.00 | 650,059.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 650,059.00 |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | 319,694.00 |
| Mar 31, 2025 | 226,329.00 |
| Sep 30, 2024 | -1.52 Mn |
| Sep 30, 2023 | -760,141.00 |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 410,461.00 |
| Sep 30, 2019 | -451,954.00 |
| Mar 31, 2018 | -1.82 Mn |
| Mar 31, 2017 | -257,151.00 |
| Sep 30, 2016 | -302,301.00 |
| Mar 31, 2016 | -14.08 Mn |
| Sep 30, 2015 | -1.74 Mn |
| Mar 31, 2015 | 1.47 Mn |
| Jun 30, 2014 | -1.08 Mn |
| Mar 31, 2014 | -651,499.00 |